Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Wall Street futures muted ahead of business survey data



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall Street futures muted ahead of business survey data</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window

Spirit Aero up following report of Boeing nearing buyout deal

Sarepta surges on expanded use of gene therapy

Gilead gains after long-acting HIV drug trial success

Futures: Dow, S&P 500, Nasdaq flat

Updated at 7:29 a.m. ET

By Lisa Pauline Mattackal and Ankika Biswas

June 21 (Reuters) -U.S. stock index futures were little changed on Friday as megacap tech and chip stocks lost ground, with investors awaiting manufacturing and services sectors surveys for more clues on the health of the world's largest economy.

The S&P 500 .SPX crossed the 5,500 point milestone during Thursday's session, however, both the benchmark index and the tech-heavy Nasdaq .IXIC closed lower as megacap stocks pulled back.

AI chip firm Nvidia NVDA.O dropped 1.4% in premarket trading on Friday, after losses in the previous session saw its market valuation fall back below that of Microsoft MSFT.O.

Semiconductor stocks Qualcomm QCOM.O, Micron Technology MU.O and Arm Holdings ARM.O were down between 1% and 2%, while megacaps such as Microsoft and Meta Platforms META.O were down around 0.3% each.

Wall Street's bumper gains since the final leg of 2023 has been primarily driven by the likes of Nvidia and a handful of other heavily weighted stocks linked to artificial intelligence. Analysts, however, have flagged whether the strong increase in their valuations is sustainable.

Investors are also assessing a string of weakening economic data and commentary from the U.S. Federal Reserve officials that interest rates could remain higher for longer if there is no consistent improvement in inflation numbers.

Later in the day, focus will be on flash S&P PMI readings, that are expected to fall slightly, but remain above the 50 level that shows activity is still expanding.

"Any unexpected slowdown in the U.S. economy could spark some jitters ... but investors will be hoping to see a moderation in price pressures, which would be positive for risk sentiment," said Raffi Boyadjian, lead investment analyst at forex broker XM.

Friday's session will also mark the expiry of quarterly derivatives contracts tied to stocks, index options and futures, also known as "triple witching".

"With Wall Street hit by profit taking after almost uninterrupted gains during June, there is a risk of some further volatility on Friday because of triple witching," Boyadjian said.

All three major Wall Street stock indexes are set to close the week higher, as is the small-cap focused Russell 2000 .RUT.

Money markets are pricing in a 58% chance of a 25-basis point interest rate cut at the Fed's meeting in September, and still expect about two rate cuts this year, according to LSEG's FedWatch data. FEDWATCH

At 7:29 a.m. ET, Dow e-minis 1YMcv1 were up 7 points, or 0.02%, S&P 500 e-minis EScv1 were down 1.75 points, or 0.03%, and Nasdaq 100 e-minis NQcv1 were up 2.25 points, or 0.01%.

Spirit AeroSystems SPR.N jumped 4.2% following a Reuters report that Boeing BA.N is nearing a deal to buy back the airplane parts supplier after months of talks.

Drugmaker Gilead GILD.O jumped 2.9%, extending gains from Thursday as a late-stage study showed its long-acting injectable drug was more effective in preventing HIV infection in women compared to its existing daily pill Truvada.

Sarepta Therapeutics SRPT.O soared 37.1% after the U.S. Food and Drug Administration allowed the expanded use of the company's gene therapy for patients with Duchenne muscular dystrophy aged four and older.



Reporting by Lisa Mattackal and Ankika Biswas in Bengaluru; Editing by Shounak Dasgupta

</body></html>

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.